We then collected 26 glioma tissue samples for immunohistochemistry (Table S1) and the protein level of STAP1 was significantly higher in patients with grade 4 glioma than those with grade 2–3 glioma (Fig. 1c). The gene discussed is STAP1; the disease is central nervous system cancer.